GAD2 and type 1 diabetes mellitus: It would be of interest to evaluate whether autoantibodies against neo-antigens are present in large cohorts of patients with T1D (recent-onset, longstanding, longitudinal) and in patients who are classified as autoantibody negative to the existing biomarkers (insulin, GAD65, Znt-8).